文章摘要

参考文献/References

[1]Watson T,Shantsila E,Lip GY.Mechanisms of thrombogenesis in atrial fibrillation:Virchow's triad revisited[J].Lancet,2009,373(9658):155-166.

[2]Krishnamoorthy S,Khoo CW,Lim HS,et al.Prognostic role of plasma von Willebrand factor and soluble E-selectin levels for future cardiovascular events in a‘real-world’ community cohort of patients with? atrial fibrillation[J].Eur J Clin Invest,2013,43(10):1032-1038.

[3]Freestone B,Chong AY,Nuttall S,et al.Soluble E-selectin, von Willebrand factor,soluble?thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent? atrial fibrillation[J].Chest,2007,132(4):1253-1258.

[4]Goette A,Hammwohner M,Bukowska A,et al.The impact of rapid atrial pacing on ADMA and endothelial NOS[J].Int J Cardiology,2012,154(2):141-146.

[5]Ammash N,Konik EA,McBane RD,et al.Left atrial blood stasis and von willebrand factor-ADAMTS13 homeostasis in atrial fibrillation[J].Arterioscler Thromb Vasc Biol,2011,31(11):2760-2766.

[6]Roldan V,Marin F,Muina B,et al.Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients[J].J Am Coll Cardiol,2011,57(25):2496-2504.

[7]Cervero J,Montes R,Espana F,et al.Limited ability to activate protein C confers left atrial endocardium a thrombogenic phenotype:a role in cardioembolic stroke?[J].Stroke,2011,42(9):2622-2624.

[8]Zabczyk M1,Majewski J,Lelakowski J.Thromboembolic events are associated with prolonged clotlysis time in patients with permanent atrial fibrillation[J].Pol Arch Med Wewn,2011,121(11):400-407.

[9]Acevedo M,Corbalán R,Braun S,et al.Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation[J].J Thromb Thrombolysis,2012,33(4):383-388.

[10]Cengel A,Sahinarslan A,Biberoglu G,et al.Asymmetrical dimethylarginine level in atrial fibrillation[J].Acta Cardiaol,2008,63(1):33-37.

[11]Yang L,Xiufen Q,Shuqin S,et al.Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation[J].J Interv Card Electrophysiol,2011,32(2):147-154.

[12]Xia W, Yin Z, Li J, et al. Effects of rosuvastatin on asymmetric dimethylarginine levels and early atrial fibrillation recurrence after electrical cardioversion[J].Pacing Clin Electrophysiol,2009,32(12):1562-1566.

[13]Wijffels MC,Kirchhof CJ,Dorland R,et al.Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats[J].Circulation,1995,92(7):1954-1968.

[14]Chao TF,Lu TM,Lin YJ,et al.Plasma asymmetric dimethylarginine and adverse events in patients with atrial fibrillation referred for coronary angiogram[J].PLoS One,2013,8(8):e71675.

[15]Polovina M,Potpara T,Giga V,et al.Impaired endothelial function in lone atrial fibrillation［J］. Vojnosanit Preql, 2013, 70(10):908-914.

[16]Freestone B, Chong AY, Nuttall S,et al.Impaired flow mediated dilatation as evidence of endothelial dysfunction in chronic atrial fibrillation:Relationship to plasma von Willebrand factor and soluble E-selectin levels[J].Thrombosis Research,2008,122(1):85-90.

[17]O’Neal WT,Efird JT,Yeboah J,et al.Brachial flow-mediated dilation and incident atrial fibrillation:the multi-ethnic study of atherosclerosis[J].Arterioscler Thromb Vasc Biol,2014,34(12):2717-2720.

[18]Podzolkov VI,Tarzimanoval AI,Mokhammadi LN.The altered endothelial function in patients with arterial hypertension and different forms of atrial fibrillation[J].Klin Med(Mosk),2014,92(3):42-46.

[19]Scridon A,Girerd N,Rugeri L,et al.Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients[J].Europace,2013,15(11):1562-1566.

[20]Matsue Y,Suzuki M,Abe M,et al.Endothelial dysfunction in paroxysmal atrial fibrillation as a prothrombotic state.Comparison with permanent/persistent atrial fibrillation[J].J Atheroscler Thromb,2011,18(4):298-304.

[21]Li-Saw-Hee FL,Blann AD,Gurney D,et al.Plasma von Willebrand factor,fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation.Effects of cardioversion and return of left atrial function[J].J Thromb Thrombolysis,2003,16(3):155-161.

[22]Mondillo S,Sabatini L,Agricola E,et al.Correlation between left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic nonrheumatic atrial fibrillation[J].Int J Cardiol,2000,75(2-3):227-232.

[23]Perri L,Pastori D,Pignatelli P,et al.Flow-mediated dilation is associated with cardiovascular events in non-valvular atrial fibrillation patients[J].Int J Cardiol,2015,179(2015):139-143.

[24]Toda N,Tanabe S,Nakanishi S.Nitric oxide-mediated coronary flow regulation in patients with coronary artery disease: recent advances[J].Int J Angiol,2011,20(3):121-134.

[25]Szymanski FM,Filipiak KJ,Platek AE,et al.Can thromboembolic risk be associated with erectile dysfunction in atrial fibrillation patients?[J].Cardiol J,2015,22(4):446-452.

[26]Blann AD,Lip GY.Atrial fibrillation and thrombosis: The missing molecular links[J].J Am Coll Cardiol,2013,61(8):861-862.

[27]Jen N,Yu F,Lee J,et al.Atrial fibrillation pacing decreases intravascular shear stress in a New Zealand white rabbit model: implications in endothelial function[J].Biomech Model Mechanobiol,2013,12(4):735-745.

[28]Reilly SN,Jayaram R,Nahar K,et al.Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation:implications for the antiarrhythmic effect of statins[J].Circulation,2011,124(10):1107-1117.

[29]Dudley SC Jr,Hoch NE,McCann LA,et al.Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage:role of the NADPH and xanthine oxidases[J].Circulation,2005,112(9):1266-1273.

[30]Cho KI,Koo SH,Cha TJ,et al.Simvastatin attenuates the oxidative stress, endothelial thrombogenicity and the inducibility of atrial fibrillation in a rat model of ischemic heart failure[J].Int J Mol Sci,2014,15(8):14803-14818.

[31]McCarty MF.Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies[J].Med Hypotheses,2010,75(2):141-147.

[32]Guo Y,Lip GY,Apostolakis S.Inflammatory biomarkers and atrial fibrillation:potential role of inflammatory pathways in the pathogenesis of atrial fibrillation-induced thromboembolism[J].Curr Vasc Pharmacol,2015,13(2):192-201.

[33]Tousoulis D,Zisimos K,Antoniades C,et al.Oxidative stress and inflammatory process in patients with atrial fibrillation:the role of left atrium distension[J].Int J Cardiol,2009,136(3):258-262.

[34]Nagayama T,Hirooka Y,Kishi T,et al.Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats[J].Am J Hypertens,2015,28(4):444-451.

[35]Cardin S,Li D,Thorin-Trescases N,et al.Evolution of the atrial fibrillation substrate in experimental congestive heart failure:angiotensin-dependent and -independent pathways[J].Cardiovasc Res,2003,60(2):315-325.

[36]Hernanz R,Martinez RS,Palacios R,et al.Toll-like receptor 4 contributes to vascular remodeling and endothelial dysfunction in angiotensin II-induced hypertension[J].Br J Pharmacol,2015,172(12):3159-3176.

[37]Maguy A,Hebert TE,Nattel S.Involvement of lipid raft and caveolae in cardiac ion channel function[J].Cardiovasc Res,2006,69(4):798-807.

[38]Shin SY,Na JO,Lim HE,et al.Improved endothelial function in patients with atrial fibrillation through maintenance of sinus rhythm by successful catheter ablation[J].J Cardiovasc Electrophysiol,2011,22(4):376-382.

[39]Lim HS,Willoughby SR,Schultz C,et al.Successful catheter ablation decreases platelet activation and improves endothelial function in patients with atrial fibrillation[J].Heart Rhythm,2014,11(11):1912-1918.

[40]Nikitovic D,Zacharis EA,Manios EG,et al.Plasma levels of nitrites/nitrates in patients with chronic atrial fibrillation are increased after electrical restoration of sinus rhythm[J].J Interv Card Electrophysiol,2002,7(2):171-176.

[41]Guazzi M,Belletti S,Tumminello G,et al.Exercise hyperventilation,dyspnea sensation,and ergoreflex activation in lone atrial fibrillation[J].Am J Physiol Heart Circ Physiol,2004,287(6):H2899-H2905.

我们的网站为什么显示成这样？

心房颤动与内皮功能障碍

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics